* Currencies little moved on coronavirus vaccine progress * Growing unease about current rise in new infections * Traders in Asia focus on yuan's rise against greenback By Stanley White TOKYO, Nov 17 (Reuters) - The dollar steadied against most currencies on Tuesday as a return of coronavirus restrictions in some U.S. states and worries about a smooth transition for President-elect Joe Biden offset optimism about a coronavirus vaccine. The British pound edged higher on media reports the UK could reach a post-Brexit trade agreement with the European Union by early next week. Moderna became the second U.S. pharmaceutical company in a week to report positive results from trials of a COVID-19 vaccine, considered necessary to eradicate the pandemic. Last week, encouraging progress in coronavirus vaccine testing helped the dollar rise against the safe-harbour yen and the Swiss franc. However, reaction in the currency market to subsequent developments has been subdued as the United States struggles to contain a second wave of infections, and with vaccine distribution not expected any time soon. There is also some uncertainty about Biden's plans to tackle the coronavirus and stimulate the economy as the Trump administration resists cooperation with Biden's transition team. "The market reaction has been limited because it will take time to distribute the vaccine, and there is uncertainty about U.S. politics," said Masafumi Yamamoto, chief foreign exchange strategist at Mizuho Securities in Tokyo. "Unless we clear that hurdle, the dollar won't rise. The dollar looks particularly weak against the yuan." The dollar was quoted at $1.1858 per euro, on course for its fourth straight session of declines. Sterling edged up to $1.3221 and also gained to 89.71 pence per euro. The greenback held steady at 104.52 yen Investors in the dollar are looking ahead to the release of U.S. retail sales and industrial production later on Tuesday to gauge the health of the economic recovery. However, policymakers' response to a record number of coronavirus cases, hospitalisations, and deaths in several U.S. states is likely to remain of greater concern. The dollar index against a basket of major currencies stood at 92.503, close to a one-week low. New infections are also increasing in Britain, Europe, and Japan, which further clouds the economic outlook. The Australian dollar held onto overnight gains against the greenback, while the New Zealand dollar hit its strongest in more than a year as investors scaled back bets for additional interest rate cuts. Minutes from the Reserve Bank of Australia's most recent policy meeting showed the central bank was ready to provide yet more policy stimulus if needed after cutting rates to record lows. The onshore yuan edged up to 6.5678 per dollar, approaching a 28-month high set last week, as positive economic data continues to support the currency. ======================================================== Currency bid prices at 1:04PM (0404 GMT) Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid Previous Change Session Euro/Dollar $1.1858 $1.1852 +0.06% +5.78% +1.1867 +1.1852 Dollar/Yen 104.5250 104.5250 -0.03% -3.80% +104.5750 +104.4400 Euro/Yen 123.94 123.93 +0.01% +1.63% +124.0200 +123.8700 Dollar/Swiss 0.9124 0.9124 -0.01% -5.71% +0.9125 +0.9117 Sterling/Dollar 1.3221 1.3202 +0.16% -0.30% +1.3233 +1.3192 Dollar/Canadian 1.3070 1.3073 -0.02% +0.62% +1.3078 +1.3065 Aussie/Dollar 0.7321 0.7321 +0.01% +4.34% +0.7330 +0.7312 NZ 0.6902 0.6905 -0.01% +2.60% +0.6918 +0.6894 Dollar/Dollar All spots Tokyo spots Europe spots Volatilities Tokyo Forex market info from BOJ (Reporting by Stanley White; Editing by Sam Holmes & Simon Cameron-Moore)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.